GOODRX HOLDINGS INC-CLASS A (GDRX) Fundamental Analysis & Valuation

NASDAQ:GDRX • US38246G1085

2.28 USD
-0.01 (-0.44%)
At close: Mar 6, 2026
2.27 USD
-0.01 (-0.44%)
After Hours: 3/6/2026, 8:22:15 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This GDRX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to GDRX. GDRX was compared to 35 industry peers in the Health Care Technology industry. GDRX scores excellent on profitability, but there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on GDRX. These ratings would make GDRX suitable for value investing!


Dividend Valuation Growth Profitability Health

7

1. GDRX Profitability Analysis

1.1 Basic Checks

  • GDRX had positive earnings in the past year.
  • GDRX had a positive operating cash flow in the past year.
  • In multiple years GDRX reported negative net income over the last 5 years.
  • GDRX had a positive operating cash flow in each of the past 5 years.
GDRX Yearly Net Income VS EBIT VS OCF VS FCFGDRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M

1.2 Ratios

  • GDRX has a better Return On Assets (2.17%) than 85.71% of its industry peers.
  • GDRX has a Return On Equity of 4.94%. This is amongst the best in the industry. GDRX outperforms 91.43% of its industry peers.
  • The Return On Invested Capital of GDRX (5.97%) is better than 88.57% of its industry peers.
Industry RankSector Rank
ROA 2.17%
ROE 4.94%
ROIC 5.97%
ROA(3y)0.93%
ROA(5y)-0.17%
ROE(3y)2.01%
ROE(5y)-0.21%
ROIC(3y)N/A
ROIC(5y)N/A
GDRX Yearly ROA, ROE, ROICGDRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

1.3 Margins

  • GDRX has a Profit Margin of 3.82%. This is amongst the best in the industry. GDRX outperforms 88.57% of its industry peers.
  • Looking at the Operating Margin, with a value of 10.98%, GDRX belongs to the top of the industry, outperforming 91.43% of the companies in the same industry.
  • In the last couple of years the Operating Margin of GDRX has grown nicely.
  • With an excellent Gross Margin value of 92.77%, GDRX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • In the last couple of years the Gross Margin of GDRX has remained more or less at the same level.
Industry RankSector Rank
OM 10.98%
PM (TTM) 3.82%
GM 92.77%
OM growth 3Y71.11%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.46%
GM growth 5Y-0.39%
GDRX Yearly Profit, Operating, Gross MarginsGDRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. GDRX Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so GDRX is destroying value.
  • The number of shares outstanding for GDRX has been reduced compared to 1 year ago.
  • GDRX has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for GDRX has been reduced compared to a year ago.
GDRX Yearly Shares OutstandingGDRX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
GDRX Yearly Total Debt VS Total AssetsGDRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • GDRX has an Altman-Z score of 0.30. This is a bad value and indicates that GDRX is not financially healthy and even has some risk of bankruptcy.
  • GDRX has a Altman-Z score of 0.30. This is comparable to the rest of the industry: GDRX outperforms 51.43% of its industry peers.
  • GDRX has a debt to FCF ratio of 5.20. This is a neutral value as GDRX would need 5.20 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 5.20, GDRX is in line with its industry, outperforming 60.00% of the companies in the same industry.
  • A Debt/Equity ratio of 0.78 indicates that GDRX is somewhat dependend on debt financing.
  • GDRX's Debt to Equity ratio of 0.78 is on the low side compared to the rest of the industry. GDRX is outperformed by 82.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 5.2
Altman-Z 0.3
ROIC/WACC0.59
WACC10.11%
GDRX Yearly LT Debt VS Equity VS FCFGDRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M -400M 600M 800M

2.3 Liquidity

  • GDRX has a Current Ratio of 2.61. This indicates that GDRX is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of GDRX (2.61) is comparable to the rest of the industry.
  • A Quick Ratio of 2.61 indicates that GDRX has no problem at all paying its short term obligations.
  • GDRX has a Quick ratio (2.61) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.61
Quick Ratio 2.61
GDRX Yearly Current Assets VS Current LiabilitesGDRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. GDRX Growth Analysis

3.1 Past

  • GDRX shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.06%.
  • Measured over the past 5 years, GDRX shows a small growth in Earnings Per Share. The EPS has been growing by 5.27% on average per year.
  • The Revenue has been growing slightly by 0.57% in the past year.
  • Measured over the past years, GDRX shows a small growth in Revenue. The Revenue has been growing by 7.67% on average per year.
EPS 1Y (TTM)6.06%
EPS 3Y5.27%
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)0.57%
Revenue growth 3Y1.3%
Revenue growth 5Y7.67%
Sales Q2Q%-1.91%

3.2 Future

  • The Earnings Per Share is expected to grow by 26.73% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, GDRX will show a small growth in Revenue. The Revenue will grow by 2.85% on average per year.
EPS Next Y4.89%
EPS Next 2Y10.97%
EPS Next 3Y12.61%
EPS Next 5Y26.73%
Revenue Next Year-2.7%
Revenue Next 2Y1.43%
Revenue Next 3Y2.95%
Revenue Next 5Y2.85%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
GDRX Yearly Revenue VS EstimatesGDRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
GDRX Yearly EPS VS EstimatesGDRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.2 0.4 0.6 0.8

More info and screens

Find the best growth stocksShow best growing peers

9

4. GDRX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 6.51, which indicates a rather cheap valuation of GDRX.
  • Compared to the rest of the industry, the Price/Earnings ratio of GDRX indicates a rather cheap valuation: GDRX is cheaper than 97.14% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.29. GDRX is valued rather cheaply when compared to this.
  • A Price/Forward Earnings ratio of 6.21 indicates a rather cheap valuation of GDRX.
  • Based on the Price/Forward Earnings ratio, GDRX is valued cheaply inside the industry as 94.29% of the companies are valued more expensively.
  • GDRX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.57.
Industry RankSector Rank
PE 6.51
Fwd PE 6.21
GDRX Price Earnings VS Forward Price EarningsGDRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • GDRX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. GDRX is cheaper than 91.43% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of GDRX indicates a rather cheap valuation: GDRX is cheaper than 91.43% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 8.32
EV/EBITDA 5.85
GDRX Per share dataGDRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

  • GDRX's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • GDRX has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as GDRX's earnings are expected to grow with 12.61% in the coming years.
PEG (NY)1.33
PEG (5Y)N/A
EPS Next 2Y10.97%
EPS Next 3Y12.61%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. GDRX Dividend Analysis

5.1 Amount

  • No dividends for GDRX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

GDRX Fundamentals: All Metrics, Ratios and Statistics

GOODRX HOLDINGS INC-CLASS A

NASDAQ:GDRX (3/6/2026, 8:22:15 PM)

After market: 2.27 -0.01 (-0.44%)

2.28

-0.01 (-0.44%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)02-25
Earnings (Next)05-05
Inst Owners50.75%
Inst Owner Change6.02%
Ins Owners11.19%
Ins Owner Change13.08%
Market Cap781.06M
Revenue(TTM)796.85M
Net Income(TTM)30.44M
Analysts71.43
Price Target4.65 (103.95%)
Short Float %11.33%
Short Ratio3.18
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-8.52%
Min EPS beat(2)-13.38%
Max EPS beat(2)-3.65%
EPS beat(4)0
Avg EPS beat(4)-8.7%
Min EPS beat(4)-13.38%
Max EPS beat(4)-3.65%
EPS beat(8)1
Avg EPS beat(8)-7.27%
EPS beat(12)5
Avg EPS beat(12)-0.32%
EPS beat(16)9
Avg EPS beat(16)11.67%
Revenue beat(2)0
Avg Revenue beat(2)-1.2%
Min Revenue beat(2)-1.22%
Max Revenue beat(2)-1.19%
Revenue beat(4)0
Avg Revenue beat(4)-1.83%
Min Revenue beat(4)-3.3%
Max Revenue beat(4)-1.19%
Revenue beat(8)0
Avg Revenue beat(8)-1.87%
Revenue beat(12)0
Avg Revenue beat(12)-2.02%
Revenue beat(16)2
Avg Revenue beat(16)-1.42%
PT rev (1m)-3.77%
PT rev (3m)-10.89%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.11%
EPS NY rev (1m)-0.19%
EPS NY rev (3m)-5.29%
Revenue NQ rev (1m)-0.17%
Revenue NQ rev (3m)0.41%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.99%
Valuation
Industry RankSector Rank
PE 6.51
Fwd PE 6.21
P/S 0.98
P/FCF 8.32
P/OCF 4.65
P/B 1.27
P/tB N/A
EV/EBITDA 5.85
EPS(TTM)0.35
EY15.35%
EPS(NY)0.37
Fwd EY16.1%
FCF(TTM)0.27
FCFY12.02%
OCF(TTM)0.49
OCFY21.5%
SpS2.33
BVpS1.8
TBVpS-0.05
PEG (NY)1.33
PEG (5Y)N/A
Graham Number3.76
Profitability
Industry RankSector Rank
ROA 2.17%
ROE 4.94%
ROCE 7.56%
ROIC 5.97%
ROICexc 7.71%
ROICexgc 26.32%
OM 10.98%
PM (TTM) 3.82%
GM 92.77%
FCFM 11.78%
ROA(3y)0.93%
ROA(5y)-0.17%
ROE(3y)2.01%
ROE(5y)-0.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y49.69%
ROICexgc growth 5YN/A
ROICexc growth 3Y64.86%
ROICexc growth 5YN/A
OM growth 3Y71.11%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.46%
GM growth 5Y-0.39%
F-Score6
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 5.2
Debt/EBITDA 2.8
Cap/Depr 86.86%
Cap/Sales 9.29%
Interest Coverage 2.14
Cash Conversion 97.22%
Profit Quality 308.43%
Current Ratio 2.61
Quick Ratio 2.61
Altman-Z 0.3
F-Score6
WACC10.11%
ROIC/WACC0.59
Cap/Depr(3y)79.94%
Cap/Depr(5y)88.33%
Cap/Sales(3y)8.53%
Cap/Sales(5y)7.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.06%
EPS 3Y5.27%
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y4.89%
EPS Next 2Y10.97%
EPS Next 3Y12.61%
EPS Next 5Y26.73%
Revenue 1Y (TTM)0.57%
Revenue growth 3Y1.3%
Revenue growth 5Y7.67%
Sales Q2Q%-1.91%
Revenue Next Year-2.7%
Revenue Next 2Y1.43%
Revenue Next 3Y2.95%
Revenue Next 5Y2.85%
EBIT growth 1Y32.63%
EBIT growth 3Y73.33%
EBIT growth 5YN/A
EBIT Next Year18.11%
EBIT Next 3Y10.62%
EBIT Next 5Y8.31%
FCF growth 1Y-17.32%
FCF growth 3Y0.82%
FCF growth 5Y-0.34%
OCF growth 1Y-8.69%
OCF growth 3Y4.58%
OCF growth 5Y5.04%

GOODRX HOLDINGS INC-CLASS A / GDRX FAQ

Can you provide the ChartMill fundamental rating for GOODRX HOLDINGS INC-CLASS A?

ChartMill assigns a fundamental rating of 6 / 10 to GDRX.


What is the valuation status for GDRX stock?

ChartMill assigns a valuation rating of 9 / 10 to GOODRX HOLDINGS INC-CLASS A (GDRX). This can be considered as Undervalued.


What is the profitability of GDRX stock?

GOODRX HOLDINGS INC-CLASS A (GDRX) has a profitability rating of 7 / 10.


What is the earnings growth outlook for GOODRX HOLDINGS INC-CLASS A?

The Earnings per Share (EPS) of GOODRX HOLDINGS INC-CLASS A (GDRX) is expected to grow by 4.89% in the next year.